Afobazol 10 mg 60 pcs
Afobazole 10 mg 60 pcs
If this product is temporarily out of stock, consider: Bafazol 10 mg 40 pcs
Key ingredient:
1 peice contains:
fabomotizole (fabomotizole hydrochloride) 10 mg;
other ingredients: potato starch, microcrystalline cellulose, lactose monohydrate, povidone, magnesium stearate
Usage form
Pieces are white or creamy white, flat cylindrical with a bevel.
Pharmacotherapeutic group
Anxiolytics.
Afobazole is a derivative of 2-mercaptobenzimidazole, a selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists. Prevents the development of membrane-dependent changes in the GABA receptor.
The product has an anxiolytic effect with an activating component, not accompanied by hypnosedative effects (sedative effect is manifested in doses 40-50 times exceeding ED50 for anxiolytic effect). The product does not have muscle relaxant properties, negative impact on memory and attention. When using it, product dependence does not form and withdrawal syndrome does not develop. The effect of the product is realized mainly through a combination of anxiolytic (eliminating anxiety) and stimulating (activating) effects. Reduction or elimination of anxiety (concern, bad feelings, fears, irritability), tension (timidity, tearfulness, feeling of restlessness, inability to relax, insomnia, fear), and consequently - somatic (muscular, sensory, cardiovascular gastrointestinal discomfort), vegetative (dry mouth, sweating, dizziness), cognitive (difficulty concentrating, poor memory) disorders are observed on the 5-7th day of support with the product. The maximum effect is achieved by the end of the 4th week of support and persists after discontinuation of the product for an average of 1-2 weeks. The product is especially indicated for use in asthenic individuals with anxiety, lack of confidence,
Indications
Anxiety states:
• generalized anxiety disorders,
• neurasthenia,
• adaptation disorders in patients with dermatological,
• oncological,
• somatic (bronchial asthma, irritable bowel syndrome, systemic lupus erythematosus, ischemic heart condition, arterial hypertension, arrhythmia) conditions.
• As part of complex support of sleep disorders associated with anxiety, neurocirculatory dystonia, premenstrual syndrome, alcohol withdrawal syndrome, to alleviate the condition during smoking cessation syndrome.
Contraindications of Afobazole
Hypersensitivity to the components of the product.
On the Afobazol page you will find alternative versions and forms of this product.
Original: $39.99
-65%$39.99
$14.00


Description
Afobazole 10 mg 60 pcs
If this product is temporarily out of stock, consider: Bafazol 10 mg 40 pcs
Key ingredient:
1 peice contains:
fabomotizole (fabomotizole hydrochloride) 10 mg;
other ingredients: potato starch, microcrystalline cellulose, lactose monohydrate, povidone, magnesium stearate
Usage form
Pieces are white or creamy white, flat cylindrical with a bevel.
Pharmacotherapeutic group
Anxiolytics.
Afobazole is a derivative of 2-mercaptobenzimidazole, a selective anxiolytic that does not belong to the class of benzodiazepine receptor agonists. Prevents the development of membrane-dependent changes in the GABA receptor.
The product has an anxiolytic effect with an activating component, not accompanied by hypnosedative effects (sedative effect is manifested in doses 40-50 times exceeding ED50 for anxiolytic effect). The product does not have muscle relaxant properties, negative impact on memory and attention. When using it, product dependence does not form and withdrawal syndrome does not develop. The effect of the product is realized mainly through a combination of anxiolytic (eliminating anxiety) and stimulating (activating) effects. Reduction or elimination of anxiety (concern, bad feelings, fears, irritability), tension (timidity, tearfulness, feeling of restlessness, inability to relax, insomnia, fear), and consequently - somatic (muscular, sensory, cardiovascular gastrointestinal discomfort), vegetative (dry mouth, sweating, dizziness), cognitive (difficulty concentrating, poor memory) disorders are observed on the 5-7th day of support with the product. The maximum effect is achieved by the end of the 4th week of support and persists after discontinuation of the product for an average of 1-2 weeks. The product is especially indicated for use in asthenic individuals with anxiety, lack of confidence,
Indications
Anxiety states:
• generalized anxiety disorders,
• neurasthenia,
• adaptation disorders in patients with dermatological,
• oncological,
• somatic (bronchial asthma, irritable bowel syndrome, systemic lupus erythematosus, ischemic heart condition, arterial hypertension, arrhythmia) conditions.
• As part of complex support of sleep disorders associated with anxiety, neurocirculatory dystonia, premenstrual syndrome, alcohol withdrawal syndrome, to alleviate the condition during smoking cessation syndrome.
Contraindications of Afobazole
Hypersensitivity to the components of the product.
On the Afobazol page you will find alternative versions and forms of this product.


